Related references
Note: Only part of the references are listed.Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis
Daniela L. Buscariollo et al.
CANCER (2012)
Targeting the enhancer of zeste homologue 2 in medulloblastoma
Irina Alimova et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Epigenetic regulation of signaling pathways in cancer: Role of the histone methyltransferase EZH2
Daisy P. F. Tsang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival
Diane K. Birks et al.
NEURO-ONCOLOGY (2011)
Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells
F. Orzan et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo
Sha Hu et al.
CANCER BIOLOGY & THERAPY (2010)
Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation
Boris G. Wilson et al.
CANCER CELL (2010)
Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
Martin Sauvageau et al.
CELL STEM CELL (2010)
The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells
Ryutaro Aoki et al.
JOURNAL OF HEPATOLOGY (2010)
Enhancer of Zeste Homolog 2 Promotes the Proliferation and Invasion of Epithelial Ovarian Cancer Cells
Hua Li et al.
MOLECULAR CANCER RESEARCH (2010)
Deregulation of H3K27 methylation in cancer
Eva Martinez-Garcia et al.
NATURE GENETICS (2010)
Ezh2, the histone methyltransferase of PRC2, regulates the balance between self-renewal and differentiation in the cerebral cortex
Joao D. Pereira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis
Michiel Smits et al.
ONCOTARGET (2010)
EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
Mario-Luca Suva et al.
CANCER RESEARCH (2009)
Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid Tumor
Susan N. Chi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
Tina Branscombe Miranda et al.
MOLECULAR CANCER THERAPEUTICS (2009)
EZH1 Mediates Methylation on Histone H3 Lysine 27 and Complements EZH2 in Maintaining Stem Cell Identity and Executing Pluripotency
Xiaohua Shen et al.
MOLECULAR CELL (2008)
Conserved functions of the pRB and E2F families
Sander van den Heuvel et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors
Sharon L. Gardner et al.
PEDIATRIC BLOOD & CANCER (2008)
Genomewide Analysis of PRC1 and PRC2 Occupancy Identifies Two Classes of Bivalent Domains
Manching Ku et al.
PLOS GENETICS (2008)
Integrative genornics analysis reveals silencing of β-adrenergic signaling by polycomb in prostate cancer
Jinclan Yu et al.
CANCER CELL (2007)
Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
Jing Tan et al.
GENES & DEVELOPMENT (2007)
Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma
Rajeev Vibhakar et al.
NEURO-ONCOLOGY (2007)
The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells
Adrian P. Bracken et al.
GENES & DEVELOPMENT (2007)
Polycomb complexes repress developmental regulators in murine embryonic stem cells
LA Boyer et al.
NATURE (2006)
Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors
D Alarcon-Vargas et al.
ONCOGENE (2006)
Epigenetic therapy of cancer: past, present and future
CB Yoo et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The polycomb group protein enhancer of zeste homolog 2 (EZH2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype
PA Croonquist et al.
ONCOGENE (2005)
Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss
M Tsikitis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation
H Fujisawa et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3
R Cao et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2004)
Activated p53 suppresses the histone methyltransferase EZH2 gene
XH Tang et al.
ONCOGENE (2004)
Central nervous system atypical teratoid/rhabdoid tumor: Results of therapy in children enrolled in a registry
JM Hilden et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
AP Bracken et al.
EMBO JOURNAL (2003)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein
A Kuzmichev et al.
GENES & DEVELOPMENT (2002)
Role of histone H3 lysine 27 methylation in polycomb-group silencing
R Cao et al.
SCIENCE (2002)
Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal polycomb sites
B Czermin et al.
CELL (2002)
Histone methyltransferase activity of a Drosophila polycomb group repressor complex
J Müller et al.
CELL (2002)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma
HPJ Visser et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Share Paper
